- Lower volatility than the market (beta 0.16)
- +50.2% YTD performance
- Bullish long-term trend in place
Volatile ride for Aspire Biopharma, Inc. stock price on Tuesday moving between $5.81 and $6.50
(Updated on Jun 23, 2026)
The Aspire Biopharma, Inc. stock price fell by -1.91% on the last day (Tuesday, 23rd Jun 2026) from $6.29 to $6.17. During the last trading day the stock fluctuated 11.88% from a day low at $5.81 to a day high of $6.50. The price has been going up and down for this period, and there has been a -7.22% loss for the last 2 weeks. Volume has increased on the last day by 54 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 118 thousand shares were bought and sold for approximately $729.74 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ASBP Signals & Forecast
The Aspire Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.03 and $5.76. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 18, 2026, and so far it has fallen -7.63%. Further fall is indicated until a new bottom pivot has been found. Aspire Biopharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Aspire Biopharma, Inc. stock
Aspire Biopharma, Inc. finds support from accumulated volume at $5.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.690 between high and low, or 11.88%. For the last week, the stock has had daily average volatility of 15.29%.
Our recommended stop-loss: $5.95 (-3.59%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 24 days ago.)
Trading Expectations (ASBP) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Aspire Biopharma, Inc. to open at $6.16, and during the day (based on 14 day Average True Range), to move between $5.60 and $6.74, which gives a possible trading interval of +/-$1.14 (+/-20.30%) up or down from last closing price. If Aspire Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 20.30% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.90 (4.31%) than the resistance at $6.67 (8.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Aspire Biopharma, Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
2.307
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $6.16 ( 0.162%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ASBP Performance
Trading levels for ASBP
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.85 | 11.02% |
| R2 | 6.59 | 6.75% |
| R1 | 6.42 | 4.11% |
| Price | 6.17 | |
| S1 | 5.90 | -4.43% |
| S2 | 5.73 | -7.07% |
| S3 | 5.47 | -11.35% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.35 | 19.12% |
| R2 | 6.68 | 8.27% |
| R1 | 6.67 | 8.14% |
| Price | 6.17 | |
| S1 | 5.90 | -4.31% |
| S2 | 4.96 | -19.61% |
| S3 | 4.65 | -24.64% |
FAQ
Click here for our free guide on how to buy Aspire Biopharma, Inc. Stock.
Buy ASBP